Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10947253 Fused polycyclic dimers

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

August 5, 2019

Date of Patent

March 16, 2021

Patent Application Number

16531601

Patent Citations

US Patent 10072009 N-substituted beta-carbolinium compounds as potent P-glycoprotein inducers

US Patent 10092550 Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof

US Patent 10086000 Tricyclic compounds as inhibitors of mutant IDH enzymes

US Patent 10138242 Pyrazolopyridine derivatives and their use in therapy

US Patent 10125114 Methods to induce targeted protein degradation through bifunctional molecules

US Patent 10011614 Bis-β-carboline compound and preparation method, pharmaceutical composition and use thereof

Patent Citations Received

US Patent 12129265 Therapeutic agents and uses thereof

0

US Patent 11576902 Inhibition of COVID-19 virus

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Timothy R Rozof

Find more entities like US Patent 10947253 Fused polycyclic dimers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.